MED1 and central nervous system cancer: To further verify H3K27ac and MED1 binds the SE and promoter of LIMD1-AS1, ChIP analysis was performed to show that H3K27ac binds SE and promoter of LIMD1-AS1 in LN-18 and T98G glioma cells (Fig. 5B, C).